Trastuzumab-Induced Myocardiotoxicity Mimicking Acute Coronary Syndrome

Trastuzumab is an important biological agent in the treatment of HER2-positive breast cancer, with effects on response rates, progression-free survival, overall survival and quality of life. Although this drug is well tolerated in terms of adverse effects, trastuzumab-associated myocardiotoxicity ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Ribeiro, K.B., Miranda, C.H., Andrade, J.M., Galli, L.G., Tiezzi, D.G., Oliveira, H.F., Zola, F.E., Volpe, G., Pazin-Filho, A., Peria, F.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2012
Materias:
Published online: March, 2012
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364043/
https://www.ncbi.nlm.nih.gov/pubmed/22666200
http://dx.doi.org/10.1159/000337576

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364043/
https://www.ncbi.nlm.nih.gov/pubmed/22666200
http://dx.doi.org/10.1159/000337576

Ejemplares similares